Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 52, Issue 3, Pages 864-874
Publisher
Wiley
Online
2010-06-02
DOI
10.1002/hep.23787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients
- (2009) José del Valle et al. AIDS
- Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin
- (2009) D. A. SHERIDAN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association of Lipid Profiles With Hepatitis C Viral Load in Chronic Hepatitis C Patients With Genotype 1 or 2 Infection
- (2009) Ching-Sheng Hsu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development
- (2009) Leen Delang et al. HEPATOLOGY
- Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients
- (2009) M Cesari et al. HIV MEDICINE
- An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads
- (2009) Hitomi Sezaki et al. INTERVIROLOGY
- Does fluvastatin favour HCV replicationin vivo? A pilot study on HIV-HCV coinfected patients
- (2009) L. Milazzo et al. JOURNAL OF VIRAL HEPATITIS
- Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b
- (2009) H. Mawatari et al. JOURNAL OF VIRAL HEPATITIS
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fluvastatin Inhibits Hepatitis C Replication in Humans
- (2008) Ted Bader et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Targeting Lipid Metabolism in the Treatment of Hepatitis C Virus Infection
- (2008) Fumitake Amemiya et al. JOURNAL OF INFECTIOUS DISEASES
- Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C
- (2008) J. McHutchison et al. JOURNAL OF VIRAL HEPATITIS
- Cross-talk Between Statins and PPARα in Cardiovascular Diseases: Clinical Evidence and Basic Mechanisms
- (2008) Réjane Paumelle et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Statins Activate Human PPAR Promoter and Increase PPAR mRNA Expression and Activation in HepG2 Cells
- (2008) Makoto Seo et al. PPAR Research
- Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis C
- (2007) Michael Economou et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now